GlaxoSmithKline's Votrient now launched in UK for renal cell carcinoma; firm ... - The Pharma Letter PDF Print
The Pharma LetterGlaxoSmithKline announced on Friday that Votrient (pazopanib) is now available in the UK for the first-line treatment of patients with advanced renal cell

... read more

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.